Innovative Eyewear Inc. Series A Warrants 8/16/27 (LUCYW)
Stock · NASDAQ · Health Care
$0.025as of 10/16/2026
Price chart
Active signals
LUCYW Signal Track Record
How signals performed across all stocks →What LUCYW's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 15 | +21.4% | 67% | September 30, 2026 |
| Bollinger Band Breakout | 16 | -19.4% | 19% | July 6, 2026 |
| Volume Spike | 11 | -8.1% | 45% | January 7, 2026 |
| 200-Day Moving Average TouchActive now | 7 | -39.1% | 14% | August 7, 2026 |
| Any 20-session window (baseline) | -5.4% | 42% |
Computed by MarketWall from daily closing prices since May 31, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About LUCYW
Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names. The company a…
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- Employees
- 13
- Website
- lucyd.co
Fundamentals
- 1-day range
- Market cap
- $556.8K
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- -0.26
- Avg. volume
- 3.9K
Innovative Eyewear Inc. Series A Warrants 8/16/27 Competitors
Chosen by industry and closest market cap.
- LUCYWInnovative Eyewear Inc. Series A Warrants 8/16/27$0.0251▼ 10.36%Market cap $556.8KP/E —$0.0251$0.152
- LUCYInnovative Eyewear Inc. Common Stock$0.79▼ 6.29%Market cap $6.19MP/E —$0.65$2.05
- RXSTRxSight Inc. Common Stock$4.51▼ 3.43%Market cap $251.69MP/E —$4.4$13.22
- STAASTAAR Surgical Company Common Stock$21.27▼ 4.45%Market cap $1.15BP/E 288.93$15.59$35.87
- EYENational Vision Holdings Inc. Common Stock$17.43▼ 1.30%Market cap $1.80BP/E 27.65$14.75$30.02
- WRBYWarby Parker Inc. Class A Common Stock$23.34▼ 5.08%Market cap $3.31BP/E 365.43$14.96$31
- BLCOBausch + Lomb Corporation Common Shares$16.49▼ 1.02%Market cap $5.84BP/E —$14.44$18.92
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LUCYW Innovative Eyewear Inc. Series A Warrants 8/16/27 | $556.8K | — | $0.0251 | ▼ 10.36% | $0.0251$0.152 |
| LUCY Innovative Eyewear Inc. Common Stock | $6.19M | — | $0.79 | ▼ 6.29% | $0.65$2.05 |
| RXST RxSight Inc. Common Stock | $251.69M | — | $4.51 | ▼ 3.43% | $4.4$13.22 |
| STAA STAAR Surgical Company Common Stock | $1.15B | 288.93 | $21.27 | ▼ 4.45% | $15.59$35.87 |
| EYE National Vision Holdings Inc. Common Stock | $1.80B | 27.65 | $17.43 | ▼ 1.30% | $14.75$30.02 |
| WRBY Warby Parker Inc. Class A Common Stock | $3.31B | 365.43 | $23.34 | ▼ 5.08% | $14.96$31 |
| BLCO Bausch + Lomb Corporation Common Shares | $5.84B | — | $16.49 | ▼ 1.02% | $14.44$18.92 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Innovative Eyewear, Inc. Launches Lucyd AeroYahoo · 10/8/2026
- Innovative Eyewear Reports Record Preliminary Q3 2026 Net Sales, Up 55% Year-Over-YearYahoo · 10/6/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 174.8K
- Total value held
- $11.8K
- Institutional holders
- 4
- Unknown115.2K
- Unknown31.4K
- Unknown28.1K
- Unknown83
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Innovative Eyewear Reports 55% Q3 Sales Growth
Innovative Eyewear announced preliminary net sales for the third quarter of 2026 that rose 55% compared to the same period last year. This marks a record high for the company's quarterly revenue. The strong sales figure stands in contrast to the stock's recent technical weakness, as the warrants have been trading near their 52-week low despite the improved fundamental performance.
Innovative Eyewear Reports 55% Q3 Sales Growth. Innovative Eyewear announced preliminary net sales for the third quarter of 2026 that rose 55% compared to the same period last year. This marks a record high for the company's quarterly revenue. The strong sales figure stands in contrast to the stock's recent technical weakness, as the warrants have been trading near their 52-week low despite the improved fundamental performance.